Latest News

Friday, October 21, 2016 | Medical Studies

Vision-Specific Functioning Worse With New Visual Impairment

Vision-specific functioning worsens with progressive loss of visual acuity, especially with new-onset visual impairment, according to results from the Singapore Malay Eye Study. Numerous studies have …

Read the full story

Friday, October 21, 2016 | Management/Leadership, Ocular Therapeutix

Ocular Therapeutix Appoints Andy Hurley Chief Commercial Officer

Ocular Therapeutix announced the appointment of Andy Hurley to the newly created position of chief commercial officer, effective immediately. In this role, Mr. Hurley will be responsible for leading O…

Read the full story

Friday, October 21, 2016 | Medical Studies

Veterans Affairs Tracks 10-Year Cataract Surgery Results

Even though the average time of cataract surgery was significantly longer at the Washington DC VA Medical Center than at non-VA hospitals, results were similar, according to a large 10-year review. &q…

Read the full story

Thursday, October 20, 2016 | Medical Studies, Prevent Blindness

Prevent Blindness Study Estimates More than 8 Million Americans have Diabetic Retinopathy, Numbers Expected to Increase Significantly

Today, more than 8 million Americans have diabetic retinopathy, with that number expected to jump in the coming years, according to a study by Prevent Blindness. The study, "The Future of Vision:…

Read the full story

Thursday, October 20, 2016 | Health Care

Medicare Payment Changes Make it Easy to Avoid Penalties

Changes to the rule that overhauls physicians' pay under Medicare, announced two days ago, mean that the vast majority of ophthalmologists will not incur penalties in 2017 and 2018. "It will …

Read the full story

Thursday, October 20, 2016 | Medical Studies, American Academy of Ophthalmology

Cutting-Edge Treatments May Help People with Aging Eyes See Up Close Without Reading Glasses

Researchers are testing cutting-edge treatments for people who want to see up close without reading glasses and finding promising results, according to studies presented this week at the American Acad…

Read the full story

Thursday, October 20, 2016 | Clinical Trials

First Patient Cohort Data From BioTime’s OpRegen Clinical Trial in Dry-AMD to Be Presented at ISOPT Clinical Symposium

BioTime reported that data from the first patient cohort of the phase 1/2a clinical trial of OpRegen in the advanced form of dry age-related macular degeneration (AMD) will be presented at the In…

Read the full story

Wednesday, October 19, 2016 | Miscellaneous

AOA Calls for Change, Federal Investigation Following Data Breach

In light of an ongoing data breach affecting optometry, American Optometric Association leadership issued a profession-wide call to action to curb current and future cases of identity theft, while als…

Read the full story

Wednesday, October 19, 2016 | Cornea,Medical Studies, American Academy of Ophthalmology

Alternative to Corneal Transplantation May Improve Outcomes in People with a Degenerative Eye Disease

An innovative procedure may improve outcomes in people with a degenerative eye disease, suggest 5-year results from a study presented at AAO. Transplantation of one layer of the cornea may help people…

Read the full story

Wednesday, October 19, 2016 | Earnings & Financials, Sensimed

Sensimed Enters into a Strategic Collaboration and Financing Agreement with SEED, a Japanese Contact Lens Manufacturer

Sensimed announced the expansion of its current collaboration in Japan with SEED, a Japanese contact lens manufacturer. The agreement enables the companies to combine efforts to work to obtain r…

Read the full story

Wednesday, October 19, 2016 | Clinical Trials, SciFluor Life Sciences

SciFluor Life Sciences Announces First Patients Dosed in Retinal Program with Investigational New Drug Application for SF0166 Topical Ophthalmic Solution

SciFluor Life Sciences announced that the first patients have been dosed in both phase 1/2 trials of SF0166 topical ophthalmic solution. This represents an important step forward in the clinical inves…

Read the full story

Tuesday, October 18, 2016 | Glaucoma,Medical Studies

Promise of Gene Therapy for Glaucoma Shines Bright in Award-Winning Image

Whether you see the gossamer wings of a butterfly or the delicate opened petals of a flower, there is beauty in the eye of the beholder - a mouse retina described and visually captured by scientists a…

Read the full story

Tuesday, October 18, 2016 | Clinical Trials,Glaucoma, Envisia Therapeutics

Envisia Therapeutics Releases ENV515 (Travoprost XR) Phase 2 Data Showing 9-Month Duration Of Action After A Single Dose In Patients With Glaucoma

Envisia Therapeutics released an interim analysis of its ENV515 (travoprost XR) phase 2 trial in glaucoma patients showing clinically meaningful reduction in IOP for the entire 9-month evaluation peri…

Read the full story

Tuesday, October 18, 2016 | Medical Studies, American Academy of Ophthalmology

Patients Unsuitable for LASIK Could Benefit from Vision Surgery Using Intraocular Lenses

People who are unsuitable for LASIK because of moderate or extreme myopia or severe astigmatism may benefit from a surgical procedure using IOLs. Phakic intraocular collamer lenses, also called Phakic…

Read the full story

Monday, October 17, 2016 | Product Releases, Alcon Laboratories

Alcon Launches the CyPass Micro-Stent

Alcon announced the US launch of the CyPass Micro-Stent at the annual meeting of the American Academy of Ophthalmology meeting in Chicago. The CyPass Micro-Stent was approved by the FDA in July for us…

Read the full story
Load More